Keck School of Medicine of USC

Keck School of Medicine of USC

We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.

 

Keck School of Medicine of USC
K

Use of Genomic Assays in Managing Early Stage HR+/HER2- BC

By Keck School of Medicine of USC FEATURING Kevin Kalinsky
By Keck School of Medicine of USC FEATURING Kevin Kalinsky
51 views
February 22, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

06:14
Lilly Medical Affairs

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Feat. J. O’Shaughnessy
10th Annual USC Multi-Disciplinary Breast Cancer Symposium
31:03

Inflammatory Breast Cancer: How Can We Improve Outcomes?

Keck School of Medicine of USC

A. Lucci

53 views
23:30

Outcomes of Vascularized Submental Lymph Node Flap Transfer for Brea…

Keck School of Medicine of USC

M. Cheng

37 views
25:02

2023 Updates on Breast Cancer in Young Women

Keck School of Medicine of USC

K. Ruddy

177 views
32:59

Evolving Strategies in TNBC in 2023

Keck School of Medicine of USC

M. Pegram

46 views
27:25

Use of Genomic Assays in Managing Early Stage HR+/HER2- BC

Keck School of Medicine of USC

K. Kalinsky

51 views
29:53

Advances in Treatment of HER2+ BC in 2023

Keck School of Medicine of USC

W. Gradishar

416 views
27:45

Oncofertility Considerations in Young Breast Cancer Survivors

Keck School of Medicine of USC

I. Su

113 views